Combination Drug Treatment to Increase Neurogenesis for Neurological Disorders

Technology #11616

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Kiminobu Sugaya, Ph.D.
Patent Protection

Provisional Patent Application Filed

Key Points

  • Combination treatment for promoting neuroregeneration and suppressing inflammation
  • May be used to treat neuronal damage caused by conditions such as stroke, Alzheimer's disease, ALS, MS, Parkinson's disease, traumatic brain injury,


The University of Central Florida invention relates to a combination therapy to promote neuroregeneration consisting of 1) MS-818 to increase endogenous neural stem cells and 2) non-steroidal anti-inflammatory drugs to suppress inflammation